Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
424.00    -15.00 (-3.42%)
Bid:
426.00
Ask:
430.00
Spread: 4.00 (0.939%)
Market Cap: £208.53m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Statement

21 Dec 2010 07:00

RNS Number : 3227Y
Zotefoams PLC
21 December 2010
 



21 December 2010

 

 

Zotefoams plc("Zotefoams" or "the Company")

 

Trading Update

 

Zotefoams, which manufactures and sells high-performance foams, today provides a trading update prior to the Company's financial year end on 31 December 2010.

 

Since the Interim Management Statement dated 22 October 2010, the business has once again performed in line with our expectations, with sales in the fourth quarter anticipated to be approximately 7% ahead of the same period in 2009. The Board therefore expects profit before tax and exceptional items for the year ending 31 December 2010 to be in line with market expectations, which are based on an accounting basis consistent with 2009.1

 

Overall sales growth for the year is expected to exceed 20%. Our Azote® product range has seen strong sales growth across all major geographic markets, particularly in Asia. HPP (High-Performance Polymer) segment sales are expected to be approximately 50% above 2009 levels. Prices for LDPE, our major raw material, have remained relatively stable during the second half of 2010.

 

The Company intends to announce its preliminary results for the year ending 31 December 2010 on Tuesday, 8 March 2011.

 

 

Enquiries:

Zotefoams plc

David Stirling, Managing Director

Clifford Hurst, Finance Director 

0208 664 1600

Financial Dynamics Limited

Ben Brewerton/John Dineen

0207 831 3113

 

 

 

 

1 As described in note 9 in our Interim Report, from 1 July 2010 our 30% shareholding in MuCell Extrusion LLC will be treated in accordance with IFRS 3 (revised). The assets and liabilities of MuCell from 1 July 2010 will be included in Zotefoams' consolidated statement of financial position with a deduction in equity as a non-controlling interest, for the 70% of MuCell's net assets, to reflect the shareholding in MuCell which Zotefoams does not own. The income statement for MuCell will be consolidated in Zotefoams' consolidated income statement with a deduction as a non-controlling interest below profit after tax of 70% of MuCell's profit after tax to reflect the shareholding in MuCell that Zotefoams does not own.

 

Our internal expectations are based on exchange rates at the date of this announcement

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTTMBRTMBTTBFM
Date   Source Headline
27th May 20264:06 pmRNSNotification of Transactions of Directors/PDMRs
27th May 20264:00 pmRNSResult of the 2026 Annual General Meeting
27th May 20267:00 amRNSTrading Update
12th May 20267:00 amRNSInvestor Presentation via Investor Meet Company
11th May 20267:00 amRNSNotification of Transactions of Directors/PDMRs
7th May 20267:00 amRNSIssue of Equity
30th Apr 20261:00 pmRNSFinal Dividend Payment Date
27th Apr 20267:00 amRNS2025 Annual Report and Notice of the 2026 AGM
15th Apr 20269:24 amRNSNotification of Transactions of Directors/PDMRs
31st Mar 20266:06 pmRNSHolding(s) in Company
25th Mar 20269:35 amRNSNotification Of Transactions Of Directors/PDMRs
17th Mar 20267:00 amRNSPreliminary Results
17th Mar 20267:00 amRNSPreliminary Results
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
16th Mar 20261:24 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Mar 20267:00 amRNSPreliminary results presentation
11th Mar 20267:00 amRNSPreliminary results presentation
13th Feb 20267:00 amRNSNotification Of Transactions Of Directors/PDMRs
27th Jan 20267:00 amRNSChange of Registered Office Address
22nd Jan 20267:00 amRNSTrading Update
15th Jan 20269:57 amRNSNotification Of Transactions Of Directors/PDMRs
15th Dec 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
18th Nov 202512:39 pmRNSAcquisition of Overseas Konstellation Company S.A.
12th Nov 20254:12 pmRNSNotification Of Transactions Of Directors/PDMRs
4th Nov 20257:00 amRNSTrading Update
24th Oct 20257:00 amRNSNon-Executive Directorate Changes
14th Oct 20252:54 pmRNSNotification Of Transactions Of Directors/PDMRs
9th Oct 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Sep 20254:25 pmRNSNOTIFICATION OF TRANSACTIONS OF DIRECTORS/PDMRs
22nd Sep 20252:33 pmRNSGroup CFO succession
12th Sep 20255:11 pmRNSNotification Of Transactions Of Directors/PDMR
28th Aug 20257:00 amRNS-RInnovation Initiatives and Executive Appointment
19th Aug 20252:16 pmRNSHolding(s) in Company
14th Aug 20256:19 pmRNSHolding(s) in Company
12th Aug 20252:57 pmRNSNotification Of Transactions Of Directors/PDMR
8th Aug 20257:00 amRNSHolding(s) in Company
7th Aug 202512:14 pmRNSHolding(s) in Company
5th Aug 20257:01 amRNSJoint Venture Agreement and Executive Appointment
5th Aug 20257:00 amRNSInterim Results
29th Jul 202511:01 amRNSInvestor Presentation via Investor Meet Company
14th Jul 20252:51 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Jun 20252:41 pmRNSNotification of Transactions of Directors/PDMRs
10th Jun 20254:13 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd May 202512:30 pmRNSResult of the 2025 Annual General Meeting
22nd May 20257:00 amRNSTrading Update
13th May 202512:05 pmRNSNotification Of Transactions Of Directors/PDMRs
1st May 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
30th Apr 20257:00 amRNSGroup CFO succession
24th Apr 20257:00 amRNSNotification Of Transactions Of Directors/PDMRs
22nd Apr 20257:00 amRNS2024 Annual Report & Notice of 2025 AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.